Pharmacoepidemiological characterisation of zolpidem and zopiclone usage

European Journal of Clinical Pharmacology

Volumn 69, Issue 11, 2013, Pages 1965-1972

  Victorri Vigneau, Caroline ^a,b,d   Feuillet, F ^a,b   Wainstein, L ^a,b   Grall Bronnec, M ^b   Pivette, J ^c   Chaslerie, A ^c   Sebille V ^a,b   Jolliet, P ^a,b  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b Universite de Nantes   (France)

^c Regional Department of Health Insurance Medical Service of the Pays de la Loire   (France)

^d INSTITUT DE BIOLOGIE   (France)

Author keywords

Abuse; Pharmacodependence; Pharmacoepidemiology; Zolpidem; Zopiclone

Indexed keywords

ZOLPIDEM; ZOPICLONE;

ADULT; AGED; ARTICLE; DRUG ABUSE; DRUG USE; FEMALE; HUMAN; LATENT CLASS ANALYSIS; MAJOR CLINICAL STUDY; MALE; PATIENT CODING; PATIENT IDENTIFICATION; PATIENT SELECTION; PHARMACOEPIDEMIOLOGY; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL ANALYSIS;

AGED; AZABICYCLO COMPOUNDS; DRUG UTILIZATION; FEMALE; FRANCE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDDLE AGED; PIPERAZINES; PYRIDINES; SUBSTANCE-RELATED DISORDERS;

EID: 84886770350     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-013-1557-x     Document Type: Article

References (46)

1. Holm KJ, Goa KL (2000) Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia. Drugs 59(4):865-889
2. LRP (2002) Dependance aux hypnotiques: zolpidem et zopiclone aussi. Rev Prescr 20:675-676
3. LRP (2002) Zolpidem: classé comme psychotrope à risque d'abus. Rev Prescr 22:819
4. Briot M (2006) Report on the appropriate use of psychotropic drugs in France. Assemblée Nationale, ISSN 1249-3872; no. 3187. Office Parlementaire d'Evaluation des Politiques de Santé, Assemblée Nationale, Paris
5. Frauger E, Pauly V, Natali F et al (2011) Patterns of methylphenidate use and assessment of its abuse and diversion in two French administrative areas using a proxy of deviant behaviour determined from a reimbursement database: main trends from 2005 to 2008. CNS Drugs 25(5):415-424
6. Frauger E, Pauly V, Thirion X et al (2009) Estimation of clonazepam abuse liability: a new method using a reimbursed drug database. Int Clin Psychopharmacol 24(6):318-324
7. Micaleff J, Jolliet P, Victorri-Vigneau C et al (2008) First meeting of the French CEIP (centres d'evaluation et d'information sur la pharmacodependance). Assessment of the abuse and pharmacodependence potential during drug development. Therapie 63(1):55-65
8. Pauly V, Pradel V, Frauger E et al (2011) Evolution of opioids reimbursement since 2004 from the National Database of the General Health Insurance System. Therapie 66(4):369-372
9. Pradel V, Frauger E, Thirion X et al (2009) Impact of a prescription monitoring program on doctor-shopping for high dosage buprenorphine. Pharmacoepidemiol Drug Saf 18(1):36-43
10. Victorri-Vigneau C, Larour K, Simon D et al (2009) Creating and validating a tool able to detect fraud by prescription falsification from health insurance administration databases. Therapie 64(1):27-31
11. Victorri-Vigneau C, Sebille V, Gerardin M et al (2011) Epidemiological characterization of drug overconsumption: the example of antidepressants. J Addict Dis 30(4):342-350
12. Wainstein L, Victorri-Vigneau C, Sebille V et al (2011) Pharmacoepidemiological characterization of psychotropic drugs consumption using a latent class analysis. Int Clin Psychopharmacol 26(1):54-62
13. McCutcheon (1987) Latent class analysis. Sage university paper series on quantitative applications in the social sciences. Series no. 07-064. Sage, Newbury Park
14. Moss HB, Chen CM, Yi HY (2007) Subtypes of alcohol dependence in a nationally representative sample. Drug Alcohol Depend 91(2-3):149-158
15. Reboussin BA, Song EY, Shrestha A et al (2006) A latent class analysis of underage problem drinking: evidence from a community sample of 16-20 year olds. Drug Alcohol Depend 83(3):199-209
16. Agrawal A, Lynskey MT, Madden PA et al (2007) A latent class analysis of illicit drug abuse/dependence: results from the National Epidemiological Survey on Alcohol and Related Conditions. Addiction 102(1):94-104
17. Martin-Latry K, Begaud B (2010) Pharmacoepidemiological research using French reimbursement databases: yes we can! Pharmacoepidemiol Drug Saf 19(3):256-265
18. Latry P, Molimard M, Begaud B et al (2010) How reimbursement databases can be used to support drug utilisation studies: example using the main French national health insurance system database. Eur J Clin Pharmacol 66(7):743-748
19. Victorri-Vigneau C, Dailly E, Veyrac G et al (2007) Evidence of zolpidem abuse and dependence: results of the French Centre for Evaluation and Information on Pharmacodependence (CEIP) network survey. Br J Clin Pharmacol 64(2):198-209
20. Krueger TH, Kropp S, Huber TJ (2005) High-dose zolpidem dependence in a patient with chronic facial pain. Ann Pharmacother 39(4):773-774
21. Sethi PK, Khandelwal DC (2005) Zolpidem at supratherapeutic doses can cause drug abuse, dependence and withdrawal seizure. J Assoc Physicians India 53:139-140
22. Quaglio G, Lugoboni F, Fornasiero A et al (2005) Dependence on zolpidem: two case reports of detoxification with flumazenil infusion. Int Clin Psychopharmacol 20(5):285-287
23. Brunelle E, Rotily M, Lancon C et al (2005) Zolpidem: intravenous misuse in drug abusers. Addiction 100(9):1377-1378
24. Liappas IA, Papageorgiou CC, Rabavilas AD (2006) Abnormal auditory N400 in a case of zolpidem dependence, during a working memory test. Eur Psychiatry 21(2):135-137
25. Djezzar S, Dugarin J, Dally S (2006) Zolpidem and dextromoramide abuse with increased metabolism. Am J Addict 15(5):405-406
26. Cubala WJ, Landowski J (2007) Seizure following sudden zolpidem withdrawal. Prog Neuropsychopharmacol Biol Psychiatry 31(2):539-540
27. Askew JP (2007) Zolpidem addiction in a pregnant woman with a history of second-trimester bleeding. Pharmacotherapy 27(2):306-308
28. Huang MC, Lin HY, Chen CH (2007) Dependence on zolpidem. Psychiatry Clin Neurosci 61(2):207-208
29. Mariani JJ, Levin FR (2007) Quetiapine treatment of zolpidem dependence. Am J Addict 16(5):426
30. Benyamina A, Dublanchet O, Karila L et al (2007) Intravenous zolpidem abuse: a case for serotonin depletion. Am J Addict 16(6):534
31. Svitek J, Heberlein A, Bleich S et al (2008) Extensive craving in high dose zolpidem dependency. Prog Neuropsychopharmacol Biol Psychiatry 32(2):591-592
32. Sharan P, Bharadwaj R, Grover S et al (2007) Dependence syndrome and intoxication delirium associated with zolpidem. Natl Med J India 20(4):180-181
33. Jana AK, Arora M, Khess CR et al (2008) A case of zolpidem dependence successfully detoxified with clonazepam. Am J Addict 17(4):343-344
34. Boucher A, Assaad S, Pariset C et al (2008) Digital ischemia following injection of a crushed tablet of zolpidem: tardive improvement with iloprost. Therapie 63(6):463-467
35. Pitchot W, Ansseau M (2009) Zolpidem dependence and withdrawal seizure. Rev Med Liege 64(7-8):407-408
36. Chen CY, Shiah IS, Lee WK et al (2009) Dependence on quetiapine in combination with zolpidem and clonazepam in bipolar depression. Psychiatry Clin Neurosci 63(3):427-428
37. Spyridi S, Diakogiannis I, Nimatoudis J et al (2009) Zolpidem dependence in a geriatric patient: a case report. J Am Geriatr Soc 57(10):1962-1963
38. Damm J, Eser D, Moeller HJ et al (2010) Severe dependency on zolpidem in a patient with multiple sclerosis suffering from paraspasticity. World J Biol Psychiatry 11(2 Pt 2):516-518
39. Aggarwal A, Sharma DD (2010) Zolpidem withdrawal delirium: a case report. J Neuropsychiatry Clin Neurosci 22(4):451-o.e27-451.e28
40. Wang LJ, Ree SC, Chu CL et al (2011) Zolpidem dependence and withdrawal seizure - report of two cases. Psychiatr Danub 23(1):76-78
41. Oulis P, Nakkas G, Masdrakis VG (2011) Pregabalin in zolpidem dependence and withdrawal. Clin Neuropharmacol 34(2):90-91
42. Cimolai N (2007) Zopiclone: is it a pharmacologic agent for abuse? Can Fam Physician 53(12):2124-2129
43. Hajak G, Muller WE, Wittchen HU et al (2003) Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data. Addiction 98(10):1371-1378
44. Fung HT, Lai CH, Wong OF et al (2009) Hemolytic anemia after zopiclone overdose. Clin Toxicol (Phila) 47(9):902-903
45. Wong CP, Chiu PK, Chu LW (2005) Zopiclone withdrawal: an unusual cause of delirium in the elderly. Age Ageing 34(5):526-527
46. Haasen C, Mueller-Thomsen T, Fink T et al (2005) Zopiclone dependence after insomnia related to torticollis. Int J Neuropsychopharmacol 8(2):309-310